NCT02537197View on ClinicalTrials.gov

The Effect of Regular Naltrexone Dosing on Disordered Gamblers

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 26, 2022

Study Completion Date

May 26, 2022

Conditions
Gambling
Interventions
DRUG

Naltrexone

Regular opioid antagonist dosing of disordered gamblers

Trial Locations (1)

T2R0X7

Opioid Dependency Program, Calgary

All Listed Sponsors
collaborator

Alberta Health services

OTHER

lead

University of Calgary

OTHER

NCT02537197 - The Effect of Regular Naltrexone Dosing on Disordered Gamblers | Biotech Hunter | Biotech Hunter